IDEX Corp. (IEX) Tops Q3 EPS by 2c, Lifts FY EPS Guidance

IDEX Corp. (NYSE: IEX) reported Q3 EPS of $1.08, $0.02 better than the analyst estimate of $1.06. Revenue for the quarter came in at $574.5 million versus the consensus estimate of $563.44 million.

Based on our third quarter results and strength in orders across all three segments, we are raising full year 2017 adjusted EPS guidance to $4.25 to $4.27, with fourth quarter EPS of $1.06 to $1.08. We also reaffirm full year 2017 organic revenue growth of 5 percent, with 6 percent organic growth expected in the fourth quarter.”

For earnings history and earnings-related data on IDEX Corp. (IEX) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c